Skip to main content
OpenTrials

Clinical trial condition

Primary Mediastinal Large B-cell Lymphoma (PMBCL)

Explore clinical trials studying Primary Mediastinal Large B-cell Lymphoma (PMBCL). Study availability and eligibility vary by location and protocol.

22 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Primary Mediastinal Large B-cell Lymphoma (PMBCL) trial results

Completed

A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68)

NCT04875195

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +8 more
Locations
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site Torrance, California, United States
  • Tulane Medical Center ( Site 0110) New Orleans, Louisiana, United States
  • Anne Arundel Medical Center-Anne Arundel Oncology and Hematology ( Site 0125) Annapolis, Maryland, United States
  • Hospital Erasto Gaertner ( Site 1703) Curitiba, Paraná, Brazil
View all 27 locations
View Trial Details

Related conditions